----

----

| Radiation Oncology                             | 3626   | 3626   |
|------------------------------------------------|--------|--------|
| Radiation Therapy                              | 65     | 65     |
| Oncology                                       | 2012   | 2012   |
| Oncology Treatment Center                      | 2      | 2      |
| Oncology, Medical                              | 5616   | 5616   |
| Hematology                                     | 4488   | 4488   |
| Hematology/Oncology                            | 4174   | 4174   |
| Hospitalist                                    | 3002   | 3002   |
| Internal Medicine, Hospice and Palliative Care | 6      | 6      |
| Rheumatology                                   | 3648   | 3648   |
| Otolaryngology                                 | 177    | 177    |
| HIV/AIDS                                       | 249    | 249    |
| Periodontics                                   | 146    | 146    |
| Primary Total                                  |   | 27211  |
| Hematology/Pathology                           | 134    |   |
| Oncology, Gynecologic                          | 955    |   |
| Nurse Practitioner                             | 13574  |   |
| Radiological Physics                           | 51     |   |
| Radiology                                      | 22067  |   |
| Radiology Center                               | 23     |   |
| Radiology, Diagnostic                          | 16011  |   |
| Radiology, Nuclear                             | 227    |   |
| Radiology, Nuclear/Nuclear Medicine            | 83     |   |
| Grand Total                                    | 80336  |   |

----

| 1.      | The Seminar will include a MuGard content expert supplied by Access Pharmaceuticals. |
|-----------------------------|--------------------------------------------------------------------------------------|

| 2.   | iMedicor will market the seminar, arrange for registration and administration of the event, provide technical and presentation support including the creation of PowerPoint slides or other content support, Training for the presenter and all other activities required to create and deliver a high quality educational seminar to the target audience. |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.      | The presenter(s) will deliver their presentation from their office or home, they will work with the iMedicor production team and virtually show up and teach, iMedicor will be responsible for all other related activities. |
|-----------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.      | After the live presentation is completed, an archived version will be posted on the iMedicor site and the Access site for up to three months ( or as long as the content remains current) beyond the end of this program. |
|-----------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.      | The initial three Seminars will focus on one of the following groups per seminar Physicians, Nurse Practitioners, Both. The first seminar will be delivered two weeks prior to launch, the second one week prior to launch and the third on the day of the launch. |
|-----------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6.      | Based on the initial results iMedicor will stage up to two additional seminars over the balance of 2010, schedule to be determined. |
|------------------------|-------------------------------------------------------------------------------------------------------------------------------------|

|   | 1. | Creating an Alert Message of 1,000 characters or less, plus graphics directed to the targeted practices listed within the specialty areas in the target profile chart above.                                                                                                                                                                                                                                                                                                                                                                                       |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | 2. | The Alert message is delivered through the “ALERT SYSTEM”, which historically has a 25% to 92% open rate within the first 48 hours of delivery.                                                                                                                                                                                                                                                                                                                                                                                                        |
|   | 3. | The Alert message will be constructed in such a manner to encourage the recipient to click through to the content.                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|   | 4. | The initial Content should be a PDF fact sheet communicating the clinical study, medical benefits and other related information regarding MuGard to the target patient group.                                                                                                                                                                                                                                                                                                                                                                                      |
|   | 5. | The “Click” through respondents will be encouraged to order samples once the Content is accessed. The communication will be created by the Marketing group and designed to be delivered through iMedicor’s ClearLobby portal.                                                                                                                                                                                                                                                                                                                    |
|   | 6. | Once the initial click through to the content occurs the individual retrieving the content will have the opportunity to order samples and / or request a direct communication with Access Pharmaceuticals.                                                                                                                                                                                                                                                                                                                                                         |
|   | 7. | Access Pharma will also need to have the capacity to field direct inquiries as the Alerts may generate. These inquiries may manifest themselves in direct question through e-mail, requests for additional information, or requests for in-person visits. Initially, through Direct Medical Solutions, iMedicor’s strategic direct field sales force partner, requests for in-person appointments can be directed through that organization. The method of communication and response is customizable and controllable through ClearLobby customization TBD. |
|   | 8. | The initial “ALERT” distribution through ClearLobby would be released approximately every week for the first three months from the time of the launch, or as mutually adjusted and agreed. This distribution plan will help stabilize response to a manageable level and can be adjusted according to response as the program develops. Access will need to be able to react to sample requests and to communicate directly to those physicians requesting direct contact within a reasonable time period.                                             |

----

|   | 9.  | Direct Medical Solutions will focus their sales organization to deliver content and samples directly to targeted qualified doctors beginning the day of the launch.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | 10. | iMedicor will also promote MuGard through its on-line Strategic Partners beginning with the launch. A prime example is MedTrust On-Line. This is the on-line portal that Oncologist and related field go to for updated clinical information, new procedures and treatments. iMedicor will place a message on the front page designed to encourage a “Click” through to content inside ClearLobby. This procedure will be repeated with other network partners, all of whom will need prior approval of Access Pharma prior to launch. Each of these strategic partners has access to various targeted groups at different levels of concentration and specialty. Through iMedicor we can isolate the targeted market and communicate directly with the targeted profiled group. |
|   | 11. | Additional Content formats can be included for follow-up activities such as audio lecture files, video presentations or seminars both live and archived. iMedicor is willing to include these services at no additional cost.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

| 1.      | During the initial execution iMedicor and Access Pharmaceuticals will continue to monitor response and adjust the program accordingly. |
|-----------------------------|----------------------------------------------------------------------------------------------------------------------------------------|

| 2.      | Based on the results, iMedicor will propose a “Next Phase” marketing plan and submit the plan to Access 60 days after the initial launch. |
|-----------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.      | This plan will be designed to continue the momentum started in Phase I & II. |
|-----------------------------|----------------------------------------------------------------------------------|

| 4.      | The approach of evaluating the existing project, adjusting as required to maximize results, then building on that foundation to execute additional marketing project will be part of the iMedicor service. |
|-----------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| A.   | An initial monthly fee of $10,000 will be charged for the first 5 months. The first payment will be due 60 days prior to the launch (first payment due May 15, 2010). Each subsequent payment will be due on the monthly anniversary date of the initial payment. |
|----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| B.   | This fee will include the use of our data base, iMedicor content control system (ClearLobby), customization of ClearLobby, integration required by our strategic partners, Friends and Family  sample distribution, coordination with DMS, training of sales people and iMedicor customer service support staff and access to the “Alert” system. |
|----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| C.   | After the launch the first 250 “click” through’s to order samples will be “No Charge”. Additional “Click” through’s to order samples above the 250 minimum will be charged $20.00 per click through with a 200 “click” through maximum. Any additional “Click” through’s over the minimum (250) and the maximum billable(200) will be processed at no charge.  (NOTE: ONLY ONE SAMPLE ORDER WILL BE CHARGED PER MEDICAL PRACTICE. IN THE EVENT THAT MULTIPLE SAMPLES ARE ORDERED FROM THE SAME PRACTICE, IMEDICOR WILL PROCESS THE ORDERS BUT ONLY CHARGE ON THE INITIAL REQUEST, ONE TIME ONLY). |
|----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| D.   | Click through’s to the “request for direct communication and retrieval of content” will be processed to Access Pharma at no charge. |
|----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | iMedicor will provide a monthly billing report that will include detailed information on each qualified click through. |
|--------|------------------------------------------------------------------------------------------------------------------------|

| F.   | A qualified click through will be considered an individual physician or an office administrator or nurse. Only one click through per practice will be charged for samples. |
|----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| G.   | All practices that respond in any manner to iMedicor marketing (ie; Order samples, retrieve content, request direct communication) will be tagged as an iMedicor client. All script and or sales of Access Pharma products will be identified and become part of the ongoing success bonus as highlighted in the next section. |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| H. | iMedicor shall have the right, during normal business hours and at a place designated by Access Pharma’s CFO, to compare its records with the success bonus reports provided as the basis of payment to iMedicor from Access Pharma. |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| I.   | Access pharma will have the option to cancel this program after 90 days if a minimum of 750 requests for samples is not obtained. All other success bonus features of this agreement remain in effect. |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| J.   | Access Pharmaceuticals will have the right to cancel this agreement with 60 days written notice after launch. In the event of cancellation, the one year “tail” on this agreement, as described in the next paragraph will be in full force. IMEDICOR will accept a mutually agreed upon buyout of the “tail” agreement by mutual consent. |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| A.   | Each doctor / practice that is generated through the iMedicor marketing program will be tagged in the Access bookkeeping system |
|----------------|---------------------------------------------------------------------------------------------------------------------------------|

| B.   | iMedicor will receive a success bonus based on gross sales using the following one time threshold formula: |
|----------------|------------------------------------------------------------------------------------------------------------|

| a.   | 0 to - $2,500,000 3.5% |
|----------------|------------------------|

| b.   | $2,500,001 and over – 5% |
|----------------|--------------------------------|

| C.   | Bonus will continue to be paid while iMedicor is engaged and for a period of one year if the agreement is cancelled for any reason. |
|----------------|-------------------------------------------------------------------------------------------------------------------------------------|

| D.   | The Success bonus will be paid quarterly for the first six months then every calendar month thereafter paid on the 15th of following month. |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------|

| A.   | One hour program |
|----------------|------------------|

| B.   | Complete turn key production, administration, registration, technical and staging, archiving and usage reports as described in this proposal |
|----------------|----------------------------------------------------------------------------------------------------------------------------------------------|

| C.   | All staging, marketing, training, technical support, system usage, registration, archival services and administration |
|----------------|-----------------------------------------------------------------------------------------------------------------------|

----